— Know what they know.
Not Investment Advice

OWCP OTC

OWC Pharmaceutical Research Corp.
1W: +900.0% 1M: +0.0% 3M: +900.0% YTD: +0.0% 1Y: +0.0% 3Y: -99.9% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 48 · $4975 mcap · 497M float · 0.0000% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.000001-0.0001
Volume1,507,000
Avg Volume21
Beta-0.34
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOZiv Turner
Employees9
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2009-09-04
2 Ben Gurion Street
Ramat Gan, TA 5257334
IL
972 72 260 8004
About OWC Pharmaceutical Research Corp.

OWC Pharmaceutical Research Corp., which operates through its subsidiary One World Cannabis Ltd., primarily focuses on the research and development of cannabis-based medical products. The company is dedicated to developing cannabis-derived therapies for a variety of conditions, including multiple myeloma, psoriasis, post-traumatic stress disorder (PTSD), chronic pain, and fibromyalgia. It is also innovating with a cannabis soluble tablet delivery system. Furthermore, OWC Pharmaceutical extends its expertise by providing consulting services to both private companies and governmental agencies on international medical cannabis protocols and regulatory frameworks. Founded in 2008 as Dynamic Applications Corp., the company adopted its current name, OWC Pharmaceutical Research Corp., in December 2014. Its headquarters are located in Ramat Gan, Israel.

Latest News
No recent news

Recent Insider Trades

NameTypeSharesPriceDate
Sunbeam Management, 0 — 2020-03-23
Sunbeam Management, 43,675 — 2020-03-23
De-Saban Shmuel 0 — 2016-12-31
Bignitz Mordechai 0 — 2016-12-31
Bignitz Mordechai 0 — 2016-12-15

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms